What about the kidneys make them a hotspot for COVID-19's cytokine storm? A research team says it's the presence of a protein found on specialized renal transport cells.
Patients with diabetic kidney disease can potentially be treated with a new investigational medication that may slow the progress of their illness without harmful side effects to their hearts, according to the results of a global clinical trial announced Friday.
One therapy for Type 1 diabetes is promising -- transplanting pancreatic islets from cadavers -- but a need for immunosuppression and a reactivated autoimmunity lead to low graft viability and function after five years. Now researchers show that a protective coating of alternating layers of two biopolymers delays allograft and autoimmune-mediated rejection in mouse models of T1D.
A medication frequently used to treat diabetic macular edema, which is the most common cause of blindness in people with diabetes, is less effective when used to treat the condition in Black patients, new study results show.
The "mismatch hypothesis" argues that our bodies evolved to digest the foods that our ancestors ate, and that human bodies will struggle and largely fail to metabolize a radically new set of foods. This intuitive idea is hard to test directly, but the Turkana, a pastoralist population in remote Kenya, present a natural experiment: genetically homogenous populations whose diets stretch across a lifestyle gradient from relatively "matched" to extremely "mismatched" with their recent evolutionary history.
CNIO researchers have discovered the molecular mechanism by which coxsackievirus type B4 affects the functions and identity of beta cells that generate insulin, therefore promoting diabetes * They suggest to explore whether the potential of some drugs tested for cancer treatment in combination with antiviral therapies could be effective as a prevention and therapeutic strategy * The finding could be relevant to face the COVID-19 pandemic, since recent clinical information indicates that the SARS-CoV-2 virus might also promote diabetes in some patients
The COVID-19 pandemic has jumpstarted innovation in health care delivery and allowed for real-world testing of diabetes care models in unprecedented ways, according to a manuscript published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
A new study has found that Vietnamese-American adults who were not obese were 60% more likely to have diabetes than non-obese, non-Hispanic, White Americans, after accounting for age, sex, sociodemographic factors, smoking history and exercise level.
New research suggests that conditions such as attention deficit hyperactivity syndrome (ADHD), bipolar disorder, and even aggressive behaviors may be linked with sugar intake, and that it may have an evolutionary basis.
It's long been thought that having 'autoreactive' T cells in the pancreas was a sure sign of type 1 diabetes. Yet a new study led by scientists at La Jolla Institute for Immunology (LJI) shows that even healthy people have these cells lurking in the pancreas -- in surprisingly high numbers.